American Association for Cancer Research

SHERPA: Unknown

People

  1. Scher
    Scher
  2. Morris
    Morris
  3. Solit
    Solit
  4. Heller
    Heller
  5. Slovin
    Slovin
  6. Rosen
    Rosen
  7. Reuter
    Reuter
  8. Rathkopf
    Rathkopf
  9. Danila
    Danila
  10. Fleisher
    Fleisher

Groups

  1. Department of Medicine (139)
  2. Genitourinary Oncology Service (139)
  3. Solid Tumor Oncology Division (139)
  4. GSK Faculty (60)
  5. Sloan Kettering Institute Faculty (48)
  6. Molecular Pharmacology and Chemistry Program Faculty (39)
  7. Department of Pathology and Laboratory Medicine (37)
  8. Epidemiology and Biostatistics (36)
  9. Human Oncology and Pathogenesis Program (30)
  10. Biostatistics Service (29)
Search Within
  1. "Howard Scher"
Formats
  1. Journal Article (95)
  2. Meeting Abstract (43)
  3. Guidelines (1)
Groups
  1. Department of Medicine (139)
  2. Genitourinary Oncology Service (139)
  3. Solid Tumor Oncology Division (139)
  4. GSK Faculty (60)
  5. Sloan Kettering Institute Faculty (48)
  6. Molecular Pharmacology and Chemistry Program Faculty (39)

More Groups

People
  1. Howard Scher (139)
  2. Michael Morris (23)
  3. Carlos Cordon-Cardo (19)
  4. David Solit (19)
  5. Steven Larson (19)
  6. Glenn Heller (18)

More People

Years
  1. 2024 (2)
  2. 2022 (5)
  3. 2021 (3)
  4. 2020 (6)
  5. 2019 (7)
  6. 2018 (2)

More Years

Publications
  1. Clinical Cancer Research (85)
  2. Cancer Research (54)

Results (139)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Androgen deprivation therapy drives a distinct immune phenotype in localized prostate cancer
    Journal Article

    Dallos, M. C.; Obradovic, A. Z.; McCann, P.; Chowdhury, N.; Pratapa, A.; Aggen, D. H.; Gaffney, C.; Autio, K. A.; Virk, R. K.; De Marzo, A. M.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Microsatellite instability, tumor mutational burden, and response to immune checkpoint blockade in patients with prostate cancer
    Journal Article

    Lenis, A. T.; Ravichandran, V.; Brown, S.; Alam, S. M.; Katims, A.; Truong, H.; Reisz, P. A.; Vasselman, S.; Nweji, B.; Autio, K. A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Multilineage plasticity in prostate cancer through expansion of stem-like luminal epithelial cells with elevated inflammatory signaling
    Meeting Abstract

    Zaidi, S.; Zhao, J.; Chan, J.; Martine, R.; Wadosky, K.; Gopalan, A.; Karthaus, W.; Watson, P.; True, L.; Nelson, P.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets
    Meeting Abstract

    Tang, F.; Xu, D.; Wang, S.; Wong, C. K.; Martinez-Fundichely, A.; Lee, C.; Cohen, S.; Park, J.; Hill, C.; Eng, K.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • The impact of PIK3R1 mutations and insulin-PI3K-glycolytic pathway regulation in prostate cancer
    Journal Article

    Chakraborty, G.; Nandakumar, S.; Hirani, R.; Nguyen, B.; Stopsack, K. H.; Kreitzer, C.; Rajanala, S. H.; Ghale, R.; Mazzu, Y. Z.; Pillarsetty, N. V. K.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • The effect of corticosteroids on prostate cancer outcome following treatment with enzalutamide: A multivariate analysis of the phase III AFFIRM Trial
    Journal Article

    Zhao, J. L.; Fizazi, K.; Saad, F.; Chi, K. N.; Taplin, M. E.; Sternberg, C. N.; Armstrong, A. J.; de Bono, J. S.; Duggan, W. T.; Scher, H. I.
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Differences in prostate cancer genomes by self-reported race: Contributions of genetic ancestry, modifiable cancer risk factors, and clinical factors
    Journal Article

    Stopsack, K. H.; Nandakumar, S.; Arora, K.; Nguyen, B.; Vasselman, S. E.; Nweji, B.; McBride, S. M.; Morris, M. J.; Rathkopf, D. E.; Slovin, S. F.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Features consistent with a small-cell neuroendocrine like (SC/NE-L) transformation can be readily detected and quantified in circulating tumor cells (CTCs)
    Meeting Abstract

    Scher, H. I.; Jendrisak, A.; Gilbertson, C.; Gill, A.; Barnett, E.; Gopalan, A.; Keegan, N.; Zaidi, S.; Benoliel, H.; Emily, C.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Circulating tumor cell chromosomal instability and neuroendocrine phenotype by immunomorphology and poor outcomes in men with mCRPC treated with abiraterone or enzalutamide
    Journal Article

    Brown, L. C.; Halabi, S.; Schonhoft, J. D.; Yang, Q.; Luo, J.; Nanus, D. M.; Giannakakou, P.; Szmulewitz, R. Z.; Danila, D. C.; Barnett, E. S.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • PSA-targeted alpha-, beta-, and positron-emitting immunotheranostics in murine prostate cancer models and nonhuman primates
    Journal Article

    Veach, D. R.; Storey, C. M.; Lückerath, K.; Braun, K.; von Bodman, C.; Lamminmäki, U.; Kalidindi, T.; Strand, S. E.; Strand, J.; Altai, M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: